Search Results - Thomas R. Nirschl
- Showing 1 - 18 results of 18
-
1
Sustained CD4<sup>+</sup>T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide by Susannah G. Ellsworth, Ani Sarkis Balmanoukian, Ferdynand Kos, Christopher J. Nirschl, Thomas R. Nirschl, Stuart A. Grossman, Leo Luznik, Charles G. Drake
Published 2014Artigo -
2
Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition by Wendy Mao, Ali Ghasemzadeh, Zachary T. Freeman, Aleksandar Z. Obradovic, Matthew G. Chaimowitz, Thomas R. Nirschl, Emily McKiernan, Srinivasan Yegnasubramanian, Charles G. Drake
Published 2019Artigo -
3
Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen by Andrew B. Sharabi, Christopher J. Nirschl, Christina M. Kochel, Thomas R. Nirschl, Brian J. Francica, Esteban Velarde, Theodore L. DeWeese, Charles G. Drake
Published 2014Artigo -
4
Profiling serum antibodies with a pan allergen phage library identifies key wheat allergy epitopes by Daniel R. Monaco, Brandon Sie, Thomas R. Nirschl, Audrey C. Knight, Hugh A. Sampson, Anna Nowak‐Węgrzyn, Robert A. Wood, Robert G. Hamilton, Pamela A. Frischmeyer‐Guerrerio, H. Benjamin Larman
Published 2021Artigo -
5
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas by Jian L. Campian, Xiaobu Ye, Douglas E. Gladstone, Prakash Ambady, Thomas R. Nirschl, Ivan Borrello, Marc G. Golightly, Karen E. King, Matthias Holdhoff, Judith E. Karp, Charles G. Drake, Stuart A. Grossman
Published 2015Artigo -
6
Paucity of PD-L1 expression in prostate cancer: innate and adaptive immune resistance by Allison Martin, Thomas R. Nirschl, Christopher J. Nirschl, Brian J. Francica, Christina M. Kochel, Adrie van Bokhoven, Alan K. Meeker, M. Scott Lucia, Robert A. Anders, Angelo M. De Marzo, Charles G. Drake
Published 2015Artigo -
7
Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model by Ying‐Chun Shen, Ali Ghasemzadeh, Christina M. Kochel, Thomas R. Nirschl, Brian J. Francica, Zoila A. Lopez‐Bujanda, Maria A. Carrera Haro, Ada Tam, Robert A. Anders, Mark Selby, Alan J. Korman, Charles G. Drake
Published 2017Artigo -
8
Intravesical BCG Induces CD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer by Max Kates, Thomas R. Nirschl, Nikolai A. Sopko, Hotaka Matsui, Christina M. Kochel, Leonardo Oliveira Reis, George J. Netto, Mohammad Obaidul Hoque, Noah M. Hahn, David J. McConkey, Alex S. Baras, Charles G. Drake, Trinity J. Bivalacqua
Published 2017Artigo -
9
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma by Michael A. Gorin, Hiten D. Patel, Steven P. Rowe, Noah M. Hahn, Hans J. Hammers, Alice Pons, Bruce J. Trock, Phillip M. Pierorazio, Thomas R. Nirschl, Daniela C. Salles, Julie E. Stein, Tamara L. Lotan, Janis M. Taube, Charles G. Drake, Mohamad E. Allaf
Published 2021Artigo -
10
Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment by Yuki Muroyama, Thomas R. Nirschl, Christina M. Kochel, Zoila A. Lopez‐Bujanda, Debebe Theodros, Wendy Mao, Maria A. Carrera-Haro, Ali Ghasemzadeh, Ariel E. Marciscano, Esteban Velarde, Ada Tam, Christopher J. Thoburn, Muniza Uddin, Alan K. Meeker, Robert A. Anders, Drew M. Pardoll, Charles G. Drake
Published 2017Artigo -
11
A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target by Zachary T. Freeman, Thomas R. Nirschl, Daniel H. Hovelson, Robert J. Johnston, John Engelhardt, Mark Selby, Christina M. Kochel, Ruth Y. Lan, Jingyi Zhai, Ali Ghasemzadeh, Anuj Gupta, Alyza Skaist, Sarah J. Wheelan, Hui Jiang, Alexander T. Pearson, Linda A. Snyder, Alan J. Korman, Scott A. Tomlins, Srinivasan Yegnasubramanian, Charles G. Drake
Published 2020Artigo -
12
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma by Mira Patel, Jennifer E. Kim, Debebe Theodros, Ada Tam, Esteban Velarde, Christina M. Kochel, Brian J. Francica, Thomas R. Nirschl, Ali Ghasemzadeh, Dimitrios Mathios, Sarah Harris‐Bookman, Christopher C. Jackson, Christina Jackson, Xiaobu Ye, Phuoc T. Tran, Betty Tyler, Vladimir Coric, M. J. Selby, Henry Brem, Charles G. Drake, Drew M. Pardoll, Michael Lim
Published 2016Artigo -
13
T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer by Aleksandar Z. Obradovic, Matthew C. Dallos, Marianna Zahurak, Alan W. Partin, Edward M. Schaeffer, Ashley E. Ross, Mohamad E. Allaf, Thomas R. Nirschl, David Liu, Carolyn G. Chapman, Tanya O’Neal, Haiyi Cao, Jennifer N. Durham, Güneş Güner, Javier Baena-Del Valle, Onur Ertunç, Angelo M. De Marzo, Emmanuel S. Antonarakis, Charles G. Drake
Published 2020Artigo -
14
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy by Ariel E. Marciscano, Ali Ghasemzadeh, Thomas R. Nirschl, Debebe Theodros, Christina M. Kochel, Brian J. Francica, Yuki Muroyama, Robert A. Anders, Andrew B. Sharabi, Esteban Velarde, Wendy Mao, Kunal Chaudhary, Matthew G. Chaimowitz, John Wong, Mark Selby, Kent Thudium, Alan J. Korman, David Ulmert, Daniel L.J. Thorek, Theodore L. DeWeese, Charles G. Drake
Published 2018Artigo -
15
PD-L1 expression in medulloblastoma: an evaluation by subgroup by Allison Martin, Christopher J. Nirschl, Magda J. Polanczyk, William R. Bell, Thomas R. Nirschl, Sarah Harris‐Bookman, Jillian Phallen, Jessica Hicks, Daniel Martínez, Aleksandra Ogurtsova, Haiying Xu, Lisa Sullivan, Alan K. Meeker, Eric H. Raabe, Kenneth J. Cohen, Charles G. Eberhart, Peter C. Burger, Mariarita Santi, Janis M. Taube, Drew M. Pardoll, Charles G. Drake, Michael Lim
Published 2018Artigo -
16
Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators by Aleksandar Z. Obradovic, Casey R. Ager, Mikko Turunen, Thomas R. Nirschl, Mohsen Khosravi‐Maharlooei, Alina C. Iuga, Christopher M. Jackson, Srinivasan Yegnasubramanian, Lorenzo Tomassoni, Ester Calvo Fernández, Patrick McCann, Meri Rogava, Angelo M. De Marzo, Christina M. Kochel, Mohamad E. Allaf, Trinity J. Bivalacqua, Michael Lim, Ronald Realubit, Charles Karan, Charles G. Drake, Andrea Califano
Published 2023Artigo -
17
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers by Monali Praharaj, Fan Shen, Alex J. Lee, Liang Zhao, Thomas R. Nirschl, Debebe Theodros, Alok Kumar Singh, Xiaoxu Wang, Kenneth M. Adusei, Kara A. Lombardo, Raekwon A. Williams, Laura A. Sena, Elizabeth A. Thompson, Ada Tam, Srinivasan Yegnasubramanian, Edward J. Pearce, Robert D. Leone, Jesse Alt, Rana Rais, Barbara S. Slusher, Drew M. Pardoll, Jonathan D. Powell, Jelani C. Zarif
Published 2024Artigo -
18
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer by Karim Boudadi, Daniel L. Suzman, Valsamo Anagnostou, Wei Fu, Brandon Luber, Hao Wang, Noushin Niknafs, James R. White, John L. Silberstein, Rana Sullivan, Donna Dowling, Rana Harb, Thomas R. Nirschl, Brendan Veeneman, Scott A. Tomlins, Yipeng Wang, Adam Jendrisak, Ryon P. Graf, Ryan Dittamore, Michael A. Carducci, Mario A. Eisenberger, Michael C. Haffner, Alan K. Meeker, James R. Eshleman, Jun Luo, Victor E. Velculescu, Charles G. Drake, Emmanuel S. Antonarakis
Published 2018Artigo
Search Tools:
Related Subjects
Medicine
Cancer research
Immunology
Immune system
Immunotherapy
Internal medicine
Cancer
Biochemistry
Biology
CD8
In vitro
Prostate cancer
T cell
Cytotoxic T cell
Immune checkpoint
Oncology
Gene
Antibody
Chemistry
Genetics
Glioma
Prostate
Androgen deprivation therapy
Antigen
Bladder cancer
FOXP3
Gastroenterology
Hormone
Lymphocyte
Nivolumab